Cutting unnecessary treatment for blood disorder in pregnancy

A new test for identifying a mismatch between the blood of a pregnant woman and her baby is accurate, feasible, and could substantially reduce unnecessary treatment, finds a Bristol study published on bmj.com today.

Problems can occur if a woman's blood is Rhesus (Rh) negative but she is carrying a baby whose blood is Rh positive. This is because Rh positive blood contains a substance called RhD antigen, which passes into the mother's blood at birth. The mother then makes antibodies against the RhD positive blood.

There are usually no problems during a woman's first pregnancy, but if she goes on to have another RhD positive baby, these antibodies cross the placenta and destroy the baby's red blood cells, causing a blood disorder known as haemolytic disease that can be serious and even fatal.

To prevent this, all pregnant women have their blood tested at their first antenatal visit. RhD negative women are given one or two antiserum injections (anti-RhD immunoglobulin, derived from blood products) during the pregnancy.

However, about 38 per cent of RhD negative women are carrying an RhD negative baby, so they receive this treatment unnecessarily.

So researchers at the NHS Blood and Transplant Centre in Bristol assessed a new test for predicting a baby's blood group by "typing" its DNA in the plasma of RhD negative pregnant women.

They analysed blood samples from 1,997 women taken at or before the 28 week antenatal visit. In 96 per cent of cases, the correct RhD phenotype of the baby was predicted by the genotyping tests. This was confirmed by comparing the results obtained from cord blood samples taken at delivery.

A false positive result was obtained in 0.8 per cent (14 samples), and in only three samples (0.2 per cent) were false negative results obtained.

In 3.4 per cent of cases results were either unobtainable or inconclusive.

If these results had been applied as a guide to treatment, only 2 per cent of the women would have received anti-RhD unnecessarily, compared with 36 per cent without genotyping.

The results show that fetuses of RhD negative women can be genotyped with an acceptable level of accuracy and a low rate of false positive results, says the study’s co-author, Dr Geoff Daniels of Bristol University’s Department of Cellular and Molecular Medicine and the International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol.

Testing would avoid unnecessary treatment in about 38 per cent of RhD negative women and avert the associated discomfort, inconvenience, and risk of exposure to donor blood products that such injections entail, the study concludes.

Source: University of Bristol

Related stories:

Recommendations for children's exercise lacking say experts
Researchers from the Peninsula Medical School in Plymouth, UK, have carried out research that suggests the one hour of moderate exercise a day recommended to children from health experts may not be enough to tackle the rising problem of childhood obesity.
Surgery unnecessary for 95 percent of those with asymptomatic carotid stenosis
Research led by Dr. David Spence of Robarts Research Institute at The University of Western Ontario shows that with more intensive medical therapy, the risk of stroke has become so low that at least 95 per cent of patients with asymptomatic carotid stenosis (ACS) would be better off with medical therapy than with surgery or stenting. ACS is a narrowing in the carotid artery, which supplies blood to the brain, which has not yet resulted in a stroke or transient ischemic attack (TIA). In the United States, one-half to two-thirds of the patients being subjected to surgery for revascularization are asymptomatic.
Isoflavone dietary supplement improves the functioning of the arteries in stroke patients
A dietary supplement containing isoflavone – a chemical found in soybeans, chickpeas, legumes and clovers – can improve artery function in stroke patients according to new research published online in Europe's leading cardiology journal, the European Heart Journal today (Wednesday 24 September).
Study shows high risk women can take control of diabetes 'destiny'
(PhysOrg.com) -- Women at high risk of diabetes can reduce their body’s ‘insulin resistance’ – the most important biological risk factor for diabetes – by exercising, a British Heart Foundation study from the University of Glasgow indicates today.
A stronger future for the elderly
Experts at The University of Nottingham are to investigate the effect of nutrients on muscle maintenance in the hope of determining better ways of keeping up our strength as we get old.
Study examines link between cholesterol lowering drugs and muscle cramps
Cramps, muscle soreness, pain and weakness. Sounds like a bad day at the Olympics. No. They're the side-effects millions of people suffer when they take cholesterol-lowering drugs or statins, drugs designed to protect against a potential heart attack or stroke. Their discomfort isn't life-threatening -- just a nuisance -- but it makes many patients uncomfortable enough that they stop taking them.
World-first to predict premature births
Australian researchers and a pathology company have joined forces to develop a world-first computerised system which may reveal a way to predict premature birth with greater accuracy.
Millions face undiagnosed heart risk say researchers after mass screening
One in three people with a high risk of developing cardiovascular disease (CVD) over the next 10 years have not been diagnosed, according to a major UK study in the September issue of IJCP, the International Journal of Clinical Practice.

News discussion:

Medicine & Health news